Executive Director, Global Marketing – HIV & Emerging Viruses

Gilead Sciences•Foster City, CA

About The Position

At Gilead, our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention, as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As an Executive Director, Global Marketing – HIV & Emerging Viruses, at Gilead, you will act as a highly strategic, enterprise leadership responsible for shaping and executing the global commercial strategy for HIV and emerging virus therapies. You will directly influence long-term portfolio growth, product differentiation, and patient impact worldwide. You will operate at the intersection of R&D, Commercial, and Corporate Development, driving aligned strategy from early development through global launch and lifecycle management.

Requirements

Bachelor’s degree and 16+ years of relevant experience, OR Master’s degree and 14+ years of relevant experience, OR PhD and 14+ years of relevant experience
Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
Develop Talent - understand the skills, experience, aspirations, and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop, and realize their purpose.
Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.

Nice To Haves

Advanced degree (MBA, PhD, PharmD, or MD)
Significant experience in global pharmaceutical marketing and strategy
Proven expertise in HIV therapeutic area marketing
Strong track record in new product planning, portfolio strategy, and lifecycle management
Experience leveraging market research and forecasting to drive strategic decisions
Demonstrated ability to lead complex global, matrixed teams
Experience influencing senior stakeholders across R&D and commercial organizations
Strong project management skills with ability to manage multiple high-priority initiatives simultaneously
Ability to design and execute multi-dimensional commercial strategies at global scale

Responsibilities

Enterprise Portfolio & Strategy Leadership: Partner with the R&D Therapeutic Area Head to define and evolve a long-term global HIV strategy, positioning Gilead as a leader in innovative therapies. Identify unmet medical needs and future market opportunities using market research, analytics, and competitive intelligence. Evaluate and prioritize internal pipeline and external partnership / acquisition opportunities.
Development-to-Commercial Integration: Serve as the commercial voice on cross-functional development teams, shaping clinical strategy, target indications, and product profiles. Ensure development plans align with differentiated value propositions and market needs. Influence regulatory and medical strategies to support successful product positioning and access.
Global Product Strategy & Launch Excellence: Lead development of product profiles, positioning, branding, and messaging during clinical development. Define global value propositions supported by economic and outcomes data to enable pricing and reimbursement success. Drive launch readiness through publication strategy, naming, and competitive positioning.
Global Commercial Execution & Lifecycle Management: Own global commercial plans post-approval, including positioning, branding, and market access strategy. Partner with international affiliates to ensure consistent global strategy translated into local execution. Guide lifecycle management, including Phase IV strategy alignment and portfolio optimization.
Cross-Functional & Global Leadership: Lead matrixed, pan-regional teams across Commercial, R&D, Medical Affairs, Regulatory, and Government Affairs. Build strong partnerships to ensure aligned decision-making and execution at scale. Model Gilead leadership behaviors: inclusion, integrity, accountability, teamwork, and excellence.